Guardant Health Inc (NASDAQ: GH) started the day on Thursday, with a price decrease of -5.16% at $21.88, before settling in for the price of $23.07 at the close. Taking a more long-term approach, GH posted a 52-week range of $15.81-$37.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 49.27%. Meanwhile, its Annual Earning per share during the time was -8.88%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.12%. This publicly-traded company’s shares outstanding now amounts to $121.63 million, simultaneously with a float of $117.72 million. The organization now has a market capitalization sitting at $2.69 billion. At the time of writing, stock’s 50-day Moving Average stood at $23.32, while the 200-day Moving Average is $24.00.
Guardant Health Inc (GH) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Guardant Health Inc’s current insider ownership accounts for 4.31%, in contrast to 97.37% institutional ownership. According to the most recent insider trade that took place on Jun 04 ’24, this organization’s Director sold 100 shares at the rate of 27.87, making the entire transaction reach 2,787 in total value, affecting insider ownership by 4,621. Preceding that transaction, on Mar 18 ’24, Company’s Chief Information Officer bought 2,187 for 17.82, making the whole transaction’s value amount to 38,963. This particular insider is now the holder of 12,722 in total.
Guardant Health Inc (GH) Earnings and Revenue Records
Guardant Health Inc’s EPS increase for this current 12-month fiscal period is 24.12% and is forecasted to reach -2.78 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 29.20% through the next 5 years, which can be compared against the -8.88% growth it accomplished over the previous five years trading on the market.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Let’s observe the current performance indicators for Guardant Health Inc (GH). It’s Quick Ratio in the last reported quarter now stands at 6.07. The Stock has managed to achieve an average true range (ATR) of 1.04. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.18.
In the same vein, GH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.09, a figure that is expected to reach -0.73 in the next quarter, and analysts are predicting that it will be -2.78 at the market close of one year from today.
Technical Analysis of Guardant Health Inc (GH)
If we take a close look at the recent performances of Guardant Health Inc (NASDAQ: GH), its last 5-days Average volume was 1.47 million that shows plunge from its year to date volume of 2.04 million. During the previous 9 days, stock’s Stochastic %D was recorded 70.25% While, its Average True Range was 1.07.
Raw Stochastic average of Guardant Health Inc (GH) in the period of the previous 100 days is set at 10.30%, which indicates a major fall in contrast to 51.79% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 56.01% that was higher than 55.62% volatility it exhibited in the past 100-days period.
